Scarica l'app Stockscreener
6.45
0.62%
0.04
Profound Medical Corp Borsa (PROF) Ultime notizie
Is beaten down PROF stock a buy now? - Cantech Letter
Profound Medical (NASDAQ:PROF) Trading Down 5.3%Here's What Happened - MarketBeat
Market Sentiment Around Loss-Making Profound Medical Corp. (TSE:PRN) - Simply Wall St
Profound Medical (TSE:PRN) Hits New 12-Month LowTime to Sell? - MarketBeat
Profound Medical stock hits 52-week low at $6.61 amid market challenges - Investing.com
GAGNON SECURITIES LLC Acquires Significant Stake in Profound Med - GuruFocus.com
Profound Medical Corp.'s (TSE:PRN) Profit Outlook - Yahoo Finance
Mölnlycke Health Care Appoints New CFO - MPO-mag
(PROF) Long Term Investment Analysis - Stock Traders Daily
Profound Medical Adjusts J.P. Morgan Conference Schedule for Enhanced Visibility - TipRanks
Update: Profound Medical's Scheduled Presentation at the 43rd Annual J.P. Morgan Healthcare Conference Moved Up to 9:00am PT on January 16th - The Manila Times
Profound Medical Corp. Issues Preliminary Unaudited Revenues Report for Q4 2024 - Defense World
Stocks In Play - Baystreet.ca
Does Profound Medical (PROF) Have the Potential to Rally 100.13% as Wall Street Analysts Expect? - MSN
Stocks In Play: Profound Medical Corp. By Baystreet.ca - Investing.com Canada
Profound Medical Corp (PRN-T) QuotePress Release - The Globe and Mail
Profound Medical Corp. - Baystreet.ca
Profound Medical Corp. Provides Earnings Guidance for the Fourth Quarter and for Full Year of 2024 - Marketscreener.com
Profound Medical reports FY24 revenue above consensus - MSN
Profound Medical Reports Robust Revenue Growth and Transition to U.S. GAAP - TipRanks
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues - The Manila Times
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues - Benzinga
Profound Medical (TSE:PRN) Stock Price Down 2.2%Time to Sell? - MarketBeat
Profound Medical (TSE:PRN) Shares Down 2.2% – Here’s What Happened - Defense World
How the (PROF) price action is used to our Advantage - Stock Traders Daily
Profound Medical to Present at J.P. Morgan Healthcare Conference - TipRanks
Profound Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Key factors to consider when considering risk and progression of BPH - Urology Times
Profound Medical (TSE:PRN) soars 14% this week, taking one-year gains to 18% - Simply Wall St
Profound Medical stock reaffirmed at Buy at Lake Street on favourable setup in 2025 - Investing.com Canada
2024 Urology Times pipeline report - Urology Times
Profound Medical Corp (PRN-T) Profile - The Globe and Mail
Profound Medical stock hits 52-week low at $6.87 amid market challenges - Investing.com
Critical Survey: enVVeno Medical (NASDAQ:NVNO) versus Profound Medical (NASDAQ:PROF) - Defense World
Is This Centrally Positioned AI Healthcare Co. Set to Transform the Industry? - Streetwise Reports
Profound Medical (NASDAQ:PROF) versus Westaim (OTCMKTS:WEDXF) Critical Contrast - Defense World
Closing Bell: Profound Medical Corp Down On Thursday (PRN) - Barchart
Profound Medical Successfully Prices Public Offering to Boost Commercialization Efforts - TipRanks
Raymond James Boosts Earnings Estimates for Profound Medical - MarketBeat
Raymond James Has Positive Outlook for PROF FY2024 Earnings - MarketBeat
FY2024 EPS Estimate for Profound Medical Lifted by Analyst - Defense World
FY2024 EPS Forecast for Profound Medical Boosted by Analyst - Defense World
Profound Medical stock hits 52-week low at $7.01 amid market shifts - Investing.com Australia
Profound Medical stock hits 52-week low at $7.01 amid market shifts By Investing.com - Investing.com South Africa
Tumor Ablation Market Share, Opportunities Analysis, Recent Trends, Regional Growth And Outlook By 2033 - WhaTech
Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock - Yahoo Finance UK
Profound Medical keeps “Strong Buy” rating at Raymond James - Cantech Letter
Wellington Weekly - substack.com
Profound Medical closes UPO of common shares - Medical Buyer
Profound Medical Raises $40.25 Million in Public Offering - TipRanks
Profound Medical Announces Closing of US$40.25 Million Underwritten Public Offering of Common Shares - Financial Post
Profound Medical Secures $40.25M in Public Offering to Fuel TULSA-PRO Commercialization - StockTitan
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):